[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 1987

Lafora's DiseaseThe Role of Skin Biopsy

Author Affiliations

From the Departments of Pathology (Drs Newton and Sanchez) and Dermatology (Drs Sanchez and Smith) and the Electron Microscopy Laboratory, Division of Surgical Pathology (Mr Swedo), The University of Texas Medical Branch, Galveston.

Arch Dermatol. 1987;123(12):1667-1669. doi:10.1001/archderm.1987.01660360095019
Abstract

• Lafora's disease is a neurometabolic disease characterized by progressive myoclonus epilepsy. It is thought to be transmitted by autosomal recessive inheritance. The diagnosis of Lafora's disease is based on both clinical symptomatology and histologic detection of intracytoplasmic periodic acid-Schiff-positive inclusions, termed Lafora bodies. Despite the absence of cutaneous clinical findings, typical inclusions are present in eccrine duct cells and peripheral nerve of skin biopsies. By electron microscopy, the inclusions are electron-lucent and contain glycogenlike granules and filamentous material. Skin biopsy is a convenient and the least invasive method of establishing the diagnosis of Lafora's disease.

(Arch Dermatol 1987;123:1667-1669)

×